1. Home
  2. XYLO vs NDRA Comparison

XYLO vs NDRA Comparison

Compare XYLO & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • NDRA
  • Stock Information
  • Founded
  • XYLO 1999
  • NDRA 2007
  • Country
  • XYLO Israel
  • NDRA United States
  • Employees
  • XYLO N/A
  • NDRA N/A
  • Industry
  • XYLO
  • NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • XYLO
  • NDRA Health Care
  • Exchange
  • XYLO NYSE
  • NDRA Nasdaq
  • Market Cap
  • XYLO 3.1M
  • NDRA 3.0M
  • IPO Year
  • XYLO N/A
  • NDRA 2017
  • Fundamental
  • Price
  • XYLO $5.00
  • NDRA $3.51
  • Analyst Decision
  • XYLO
  • NDRA Strong Buy
  • Analyst Count
  • XYLO 0
  • NDRA 1
  • Target Price
  • XYLO N/A
  • NDRA $14,000.00
  • AVG Volume (30 Days)
  • XYLO 11.5K
  • NDRA 9.1K
  • Earning Date
  • XYLO 04-21-2025
  • NDRA 03-27-2025
  • Dividend Yield
  • XYLO N/A
  • NDRA N/A
  • EPS Growth
  • XYLO N/A
  • NDRA N/A
  • EPS
  • XYLO N/A
  • NDRA N/A
  • Revenue
  • XYLO $57,642,000.00
  • NDRA N/A
  • Revenue This Year
  • XYLO $16.76
  • NDRA N/A
  • Revenue Next Year
  • XYLO $5.71
  • NDRA N/A
  • P/E Ratio
  • XYLO N/A
  • NDRA N/A
  • Revenue Growth
  • XYLO N/A
  • NDRA N/A
  • 52 Week Low
  • XYLO $2.70
  • NDRA $3.46
  • 52 Week High
  • XYLO $8.83
  • NDRA $2,170.00
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 61.43
  • NDRA 28.60
  • Support Level
  • XYLO $3.77
  • NDRA $4.33
  • Resistance Level
  • XYLO $5.00
  • NDRA $4.64
  • Average True Range (ATR)
  • XYLO 0.46
  • NDRA 0.35
  • MACD
  • XYLO 0.06
  • NDRA -0.09
  • Stochastic Oscillator
  • XYLO 80.81
  • NDRA 3.12

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: